Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soticlestat Pharmacokinetics With Rifampin in Healthy Volunteers
NCT05098041Phase 1Completed
- Sponsor
- Takeda
- Start
- Nov 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of soticlestat in epilepsy, sponsored by Takeda. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Plasma Concentration-time Curve From Time 0 to Infinity and 2 more. Started Nov 2021; status: completed.
02
Drugs
soticlestat
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT05098041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05098041.